Endometrial Cancer

Using the newest approaches to diagnosis and treatment, our multidisciplinary team of endometrial cancer experts creates a care plan that’s customized for you and delivered with compassion. Our radiation oncologists offer targeted therapies, minimizing exposure to healthy tissue, and our gynecologic surgeons are experienced in minimally invasive techniques, including laparoscopic and robotic surgery. We are also home to leaders in reproductive medicine, who specialize in fertility-sparing treatments.

Clinical Trials and Research Studies

Phase 1/2

A Phase 1-2 Open-Label Dose-Finding Proof of Concept First-in-Human Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CX-2009 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors

Learn More

Phase 2

A phase 2 randomized study of an oral dual TORC1/2 inhibitor alone the dual TORC1/2 inhibitor and an oral PI3Ka inhibitor in combination weekly paclitaxel alone or the combination of weekly paclitaxel and PI3Ka inhibitor in women with advanced recurrent or persistent endometrial cancer

Learn More

Phase 2

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042 an anti-PD-1 Monoclonal Antibody in Patients with Advanced Solid Tumors

Learn More